alpha-aminopyridine has been researched along with Anemia, Hemolytic, Autoimmune in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agajanian, R; Arnold, DM; Boxer, MA; Broome, CM; Choi, M; Field, JJ; Kuter, DJ; Murakhovskaya, I; Numerof, R; Rogers, KA; Tong, S | 1 |
| Markham, A | 1 |
1 review(s) available for alpha-aminopyridine and Anemia, Hemolytic, Autoimmune
| Article | Year |
|---|---|
Fostamatinib: First Global Approval.
Topics: Aminopyridines; Anemia, Hemolytic, Autoimmune; Drug Approval; Glomerulonephritis, IGA; Humans; Morpholines; Oxazines; Purpura, Thrombocytopenic, Idiopathic; Pyridines; Pyrimidines; Syk Kinase; Treatment Outcome | 2018 |
1 trial(s) available for alpha-aminopyridine and Anemia, Hemolytic, Autoimmune
| Article | Year |
|---|---|
Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study.
Topics: Adult; Aminopyridines; Anemia, Hemolytic, Autoimmune; COVID-19; Humans; Morpholines; Oxazines; Pyridines; Pyrimidines | 2022 |